Drawing for PURAFIL

USPTO serial 78515676

PURAFIL

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
ERVIN, INGA
Law office
TMO LAW OFFICE 111 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with PURAFIL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lori N. Boatright

LORI N BOATRIGHT BLAKELY SOKOLOFF TAYLOR & ZAFMAN LLP12400 WILSHIRE BLVD FL 7LOS ANGELES, CA 90025-1019UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010surgical implants, namely, implants for cosmetic surgical applications; fluid injection needles for medical use; medical devices, namely, self-contained syringes and ampules for dispensing prepackaged hyaluronic acid and derivatives thereof alone, or in combination with other polysaccharides, and with or without lidocaine; dermal filler kits comprising of a pre-filled syringe; dermal filler kits comprising of a hyaluronic acid gel in a pre-filled syringe, injected under the skin, used to reduce or eliminate fine lines and wrinkles, fill scars and contour the lips and faceACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jan 13, 2006MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 13, 2006ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 16, 2005GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 16, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 16, 2005DOCKASSIGNED TO EXAMINER
Nov 17, 2004NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance